State of the art computer assisted immune-fluorescence tests, western blot and solid phase immunoassays are offered for most generalised and organ specific autoimmune conditions.  The immunology laboratory also provides an essential service for the monitoring of biologicals (infliximab, adalimumab, vedolizumab and ustekinumab) used for the treatment of inflammatory bowel diseases and rheumatological conditions. Screening for antibody and complement primary immune deficiency defects is also available.